Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
General and administrative $ 3,664,965 $ 1,475,000
Research and development 2,243,225 953,185
Total operating expenses 5,908,190 2,428,185
NET LOSS $ (5,908,190) $ (2,428,185)
Net loss per share of common shares, basic and diluted (in Dollars per share) $ (1.37) $ (1.23)
Weighted-average number of common shares outstanding, basic and diluted (in Shares) 4,304,918 1,978,269